🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Monitoring Coughs for the Early Detection of Worsening COPD

Recruitingn/aAges 18 Years - anyAllClinica Universidad de Navarra, Universidad de Na…
NCT07212439 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is for adults with COPD. Flare-ups of COPD, also known as exacerbations, can be serious and lead to hospital stays. The purpose of this research is to see if continuously and automatically monitoring a person's coughs can help predict these flare-ups early, before they become severe. Participants will use the Hyfe cough monitoring system, which includes a watch-like device worn on the wrist and a smartphone application. The system privately counts the number of coughs without recording any audio. Participants will also answer a short, weekly questionnaire about their COPD symptoms. This is an observational study, which means it will not change the regular medical care a participant receives. The participants and their care providers will not see the cough counts. The doctor will continue to manage their COPD as usual.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: * Must be 18 years of age or older. * Must have an existing diagnosis of COPD. * For the inpatient cohort, participants must be currently assessed as having a moderate/severe exacerbation. * For the outpatient cohort, participants must have had at least one exacerbation of any severity in the last 12 months. * For the outpatient cohort, at least one month must have passed since the last exacerbation. Exclusion criteria: * Individuals who are unable to provide informed consent. * Individuals who are unable to adhere to study procedures. * For the inpatient cohort, individuals requiring invasive or non-invasive ventilation. * Individuals who live with a person who has a chronic cough.
💊

What it tests

  • Not listed
📍

Where

3 sites
Clinica San Miguel
Pamplona, Spain
Clínica Universidad de Navarra, Universidad de Navarra
Pamplona, Spain
Servicio Navarro de Salud
Pamplona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy